CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,209,843
- in 4 filings, $2.2M under 10b5-1 plans
Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,349 | 88,880 | ||
| 2025-06-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,366 | $14.60 | $166K | 101,651 |
| 2025-06-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,348 | $1.08 | $7K | 113,017 |
| 2025-06-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,348 | 95,229 | ||
| 2025-05-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,366 | $15.29 | $174K | 106,669 |
| 2025-05-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,349 | $1.08 | $7K | 118,035 |
| 2025-05-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,349 | 101,577 | ||
| 2025-04-14 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,348 | $1.08 | $7K | 123,052 |
| 2025-04-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,966 | $13.69 | $41K | 120,086 |
| 2025-04-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −8,400 | $14.83 | $125K | 111,686 |
| 2025-04-14 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,348 | 107,926 | ||
| 2025-04-01 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +1,606 | $1.08 | $2K | 172,475 |
| 2025-04-01 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −30,574 | $15.00 | $459K | 141,901 |
| 2025-04-01 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,791 | $16.02 | $45K | 139,110 |
| 2025-04-01 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −22,406 | $16.77 | $376K | 116,704 |
| 2025-04-01 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −1,606 | 114,274 | ||
| 2025-03-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion | +6,349 | $1.08 | $7K | 170,869 |
| 2025-03-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option | −6,349 | 115,880 | ||
| 2025-02-13 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +170,000 | 170,000 | ||
| 2025-02-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion | +6,348 | $1.08 | $7K | 164,520 |
Page 8 of 12 · 239 trades